TipRanks
Wuxi Biologics (Cayman) Inc. (WXIBF)
OTHER OTC:WXIBF
US Market
WXIBF
Wuxi Biologics (Cayman)
RESEARCH TOOLSreports

Wuxi Biologics (Cayman) (WXIBF) Stock Forecast & Price Target

165 Followers
See the Price Targets and Ratings of:

WXIBF Analyst Ratings

Strong Buy
15Ratings
Strong Buy
13 Buy
2 Hold
0 Sell
Based on 15 analysts giving stock ratings to
Wuxi
Biologics (Cayman)
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

WXIBF Stock 12 Month Forecast

Average Price Target

$7.51
▲(14.83% Upside)
Based on 15 Wall Street analysts offering 12 month price targets for Wuxi Biologics (Cayman) in the last 3 months. The average price target is $7.51 with a high forecast of $8.37 and a low forecast of $5.99. The average price target represents a 14.83% change from the last price of $6.54.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"$3","6":"$6","9":"$9","4.5":"$4.5","7.5":"$7.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":8.3741877,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$8.37</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.510002119999999,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$7.51</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.990666999999999,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$5.99</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,4.5,6,7.5,9],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.185,7.276475976923076,7.367951953846154,7.45942793076923,7.550903907692308,7.6423798846153845,7.733855861538461,7.825331838461539,7.916807815384615,8.008283792307692,8.099759769230769,8.191235746153847,8.282711723076924,{"y":8.3741877,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.185,7.210000163076923,7.235000326153846,7.260000489230769,7.285000652307692,7.3100008153846145,7.3350009784615375,7.360001141538461,7.385001304615384,7.410001467692307,7.43500163076923,7.460001793846153,7.485001956923076,{"y":7.510002119999999,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.185,7.0931282307692305,7.001256461538461,6.909384692307691,6.817512923076922,6.725641153846153,6.633769384615384,6.541897615384615,6.450025846153846,6.358154076923077,6.2662823076923075,6.1744105384615375,6.082538769230768,{"y":5.990666999999999,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.125,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.6,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.04,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.22,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.278,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.075,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.55,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.7,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.425,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.6,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.305,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.185,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$8.37Average Price Target$7.51Lowest Price Target$5.99
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Guotai Haitong Analyst forecast on WXIBF
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
$8.23
Buy
25.77%
Upside
Reiterated
09/17/26
Guotai Haitong Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
Morgan Stanley Analyst forecast on WXIBF
Laurence Tam
Morgan Stanley
Morgan Stanley
$7.27
Buy
11.09%
Upside
Reiterated
09/16/26
Morgan Stanley Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
Zhongtai Securities Analyst forecast on WXIBF
Unknown Analyst
Zhongtai Securities
Not Ranked
Zhongtai Securities
$7.82
Buy
19.57%
Upside
Reiterated
09/04/26
Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from Zhongtai Securities
UBS Analyst forecast on WXIBF
Chen Chen
UBS
UBS
$6.51→$7.9
Buy
20.83%
Upside
Reiterated
09/01/26
WuXi Biologics price target raised to HK$62 from HK$51.10 at UBSWuXi Biologics price target raised to HK$62 from HK$51.10 at UBS
Citi Analyst forecast on WXIBF
Unknown Analyst
Citi
Not Ranked
Citi
$5.35→$7.9
Buy
20.83%
Upside
Reiterated
08/27/26
Citi Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
CLSA Analyst forecast on WXIBF
Unknown Analyst
CLSA
Not Ranked
CLSA
$6.62→$8.37
Buy
28.05%
Upside
Reiterated
08/27/26
CLSA Sticks to Its Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
CICC Analyst forecast on WXIBF
Unknown Analyst
CICC
Not Ranked
CICC
$6.12→$7.65
Buy
16.94%
Upside
Reiterated
08/27/26
CICC Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
Citic Securities Analyst forecast on WXIBF
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
$7.65
Buy
16.94%
Upside
Reiterated
08/27/26
Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from Citic Securities
CMB International Securities Analyst forecast on WXIBF
Jill Wu
CMB International Securities
CMB International Securities
$7.65
Buy
16.94%
Upside
Reiterated
08/27/26
WuXi Biologics: Upgraded Growth Outlook and Higher DCF-Based Target Price Support Buy Rating
Jefferies Analyst forecast on WXIBF
Cui Cui
Jefferies
Jefferies
$7.65
Buy
16.94%
Upside
Reiterated
08/27/26
Jefferies Sticks to Its Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
Bank of America Securities Analyst forecast on WXIBF
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
$7.14
Hold
9.14%
Upside
Reiterated
08/26/26
Bank of America Securities Reaffirms Their Hold Rating on Wuxi Biologics (Cayman) (WXIBF)
Goldman Sachs Analyst forecast on WXIBF
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
$5.49→$6.25
Hold
-4.50%
Downside
Reiterated
08/26/26
Wuxi Biologics (Cayman) (WXIBF) Receives a Hold from Goldman Sachs
Daiwa Analyst forecast on WXIBF
Unknown Analyst
Daiwa
Not Ranked
Daiwa
$7.52
Buy
14.99%
Upside
Reiterated
08/26/26
Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from Daiwa
Nomura Analyst forecast on WXIBF
Unknown Analyst
Nomura
Not Ranked
Nomura
$6.55→$7.68
Buy
17.37%
Upside
Reiterated
08/25/26
Wuxi Biologics (Cayman) (WXIBF) Gets a Buy from Nomura
J.P. Morgan Analyst forecast on WXIBF
Unknown Analyst
J.P. Morgan
Not Ranked
J.P. Morgan
$5.99
Buy
-8.40%
Downside
Reiterated
08/03/26
Wuxi Biologics (Cayman) (WXIBF) Gets a Buy from J.P. Morgan
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Guotai Haitong Analyst forecast on WXIBF
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
$8.23
Buy
25.77%
Upside
Reiterated
09/17/26
Guotai Haitong Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
Morgan Stanley Analyst forecast on WXIBF
Laurence Tam
Morgan Stanley
Morgan Stanley
$7.27
Buy
11.09%
Upside
Reiterated
09/16/26
Morgan Stanley Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
Zhongtai Securities Analyst forecast on WXIBF
Unknown Analyst
Zhongtai Securities
Not Ranked
Zhongtai Securities
$7.82
Buy
19.57%
Upside
Reiterated
09/04/26
Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from Zhongtai Securities
UBS Analyst forecast on WXIBF
Chen Chen
UBS
UBS
$6.51→$7.9
Buy
20.83%
Upside
Reiterated
09/01/26
WuXi Biologics price target raised to HK$62 from HK$51.10 at UBSWuXi Biologics price target raised to HK$62 from HK$51.10 at UBS
Citi Analyst forecast on WXIBF
Unknown Analyst
Citi
Not Ranked
Citi
$5.35→$7.9
Buy
20.83%
Upside
Reiterated
08/27/26
Citi Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
CLSA Analyst forecast on WXIBF
Unknown Analyst
CLSA
Not Ranked
CLSA
$6.62→$8.37
Buy
28.05%
Upside
Reiterated
08/27/26
CLSA Sticks to Its Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
CICC Analyst forecast on WXIBF
Unknown Analyst
CICC
Not Ranked
CICC
$6.12→$7.65
Buy
16.94%
Upside
Reiterated
08/27/26
CICC Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
Citic Securities Analyst forecast on WXIBF
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
$7.65
Buy
16.94%
Upside
Reiterated
08/27/26
Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from Citic Securities
CMB International Securities Analyst forecast on WXIBF
Jill Wu
CMB International Securities
CMB International Securities
$7.65
Buy
16.94%
Upside
Reiterated
08/27/26
WuXi Biologics: Upgraded Growth Outlook and Higher DCF-Based Target Price Support Buy Rating
Jefferies Analyst forecast on WXIBF
Cui Cui
Jefferies
Jefferies
$7.65
Buy
16.94%
Upside
Reiterated
08/27/26
Jefferies Sticks to Its Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
Bank of America Securities Analyst forecast on WXIBF
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
$7.14
Hold
9.14%
Upside
Reiterated
08/26/26
Bank of America Securities Reaffirms Their Hold Rating on Wuxi Biologics (Cayman) (WXIBF)
Goldman Sachs Analyst forecast on WXIBF
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
$5.49→$6.25
Hold
-4.50%
Downside
Reiterated
08/26/26
Wuxi Biologics (Cayman) (WXIBF) Receives a Hold from Goldman Sachs
Daiwa Analyst forecast on WXIBF
Unknown Analyst
Daiwa
Not Ranked
Daiwa
$7.52
Buy
14.99%
Upside
Reiterated
08/26/26
Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from Daiwa
Nomura Analyst forecast on WXIBF
Unknown Analyst
Nomura
Not Ranked
Nomura
$6.55→$7.68
Buy
17.37%
Upside
Reiterated
08/25/26
Wuxi Biologics (Cayman) (WXIBF) Gets a Buy from Nomura
J.P. Morgan Analyst forecast on WXIBF
Unknown Analyst
J.P. Morgan
Not Ranked
J.P. Morgan
$5.99
Buy
-8.40%
Downside
Reiterated
08/03/26
Wuxi Biologics (Cayman) (WXIBF) Gets a Buy from J.P. Morgan
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ARDXArdelyx
PVLAPalvella Therapeutics
CELCCelcuity
AMRXAmneal Pharmaceuticals
DNTHDianthus Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Wuxi Biologics (Cayman)

3 Months
Jialin ZhangNomura
Success Rate
6/8 ratings generated profit
75%
Average Return
+16.49%
Copying Jialin Zhang's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +16.49% per trade.
1 Year
Jialin ZhangNomura
Success Rate
7/8 ratings generated profit
88%
Average Return
+68.14%
Copying Jialin Zhang's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +68.14% per trade.
2 Years
Jialin ZhangNomura
Success Rate
7/8 ratings generated profit
88%
Average Return
+128.49%
Copying Jialin Zhang's trades and holding each position for 2 Years would result in 87.50% of your transactions generating a profit, with an average return of +128.49% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

WXIBF Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
5
4
1
0
0
Buy
6
8
18
19
14
Hold
0
0
2
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
12
21
21
16
In the current month, WXIBF has received 14 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. WXIBF average Analyst price target in the past 3 months is 7.51.
Each month's total comprises the sum of three months' worth of ratings.

WXIBF Financial Forecast

WXIBF Earnings Forecast

Next quarter’s earnings estimate for WXIBF is $0.11 with a range of $0.11 to $0.11. The previous quarter’s EPS was $0.09. WXIBF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year WXIBF has Performed in-line its overall industry.
Next quarter’s earnings estimate for WXIBF is $0.11 with a range of $0.11 to $0.11. The previous quarter’s EPS was $0.09. WXIBF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year WXIBF has Performed in-line its overall industry.

WXIBF Sales Forecast

Next quarter’s sales forecast for WXIBF is $2.08B with a range of $2.06B to $2.09B. The previous quarter’s sales results were $1.71B. WXIBF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year WXIBF has Performed in-line its overall industry.
Next quarter’s sales forecast for WXIBF is $2.08B with a range of $2.06B to $2.09B. The previous quarter’s sales results were $1.71B. WXIBF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year WXIBF has Performed in-line its overall industry.

WXIBF Stock Forecast FAQ

What is WXIBF’s average 12-month price target, according to analysts?
Based on analyst ratings, Wuxi Biologics (Cayman) Inc.’s 12-month average price target is 7.51.
    What is WXIBF’s upside potential, based on the analysts’ average price target?
    Wuxi Biologics (Cayman) Inc. has 14.83% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is WXIBF a Buy, Sell or Hold?
          Wuxi Biologics (Cayman) Inc. has a consensus rating of Strong Buy which is based on 13 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Wuxi Biologics (Cayman) Inc.’s price target?
            The average price target for Wuxi Biologics (Cayman) Inc. is 7.51. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $8.37 ,the lowest forecast is $5.99. The average price target represents 14.83% Increase from the current price of $6.54.
              What do analysts say about Wuxi Biologics (Cayman) Inc.?
              Wuxi Biologics (Cayman) Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
                How can I buy shares of WXIBF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.